NO20016366L - Mellomprodukter for syntese av benzimidazolforbindelser, og fremgangsmåte for fremstilling derav - Google Patents

Mellomprodukter for syntese av benzimidazolforbindelser, og fremgangsmåte for fremstilling derav

Info

Publication number
NO20016366L
NO20016366L NO20016366A NO20016366A NO20016366L NO 20016366 L NO20016366 L NO 20016366L NO 20016366 A NO20016366 A NO 20016366A NO 20016366 A NO20016366 A NO 20016366A NO 20016366 L NO20016366 L NO 20016366L
Authority
NO
Norway
Prior art keywords
compound
preparation
chem
formula
intermediates
Prior art date
Application number
NO20016366A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016366D0 (no
Inventor
Naoyuki Kishi
Yoshitaka Nakamura
Narumi Abe
Toyonori Takebayashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20016366D0 publication Critical patent/NO20016366D0/no
Publication of NO20016366L publication Critical patent/NO20016366L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20016366A 1999-06-28 2001-12-27 Mellomprodukter for syntese av benzimidazolforbindelser, og fremgangsmåte for fremstilling derav NO20016366L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18189899 1999-06-28
PCT/JP2000/004213 WO2001000570A1 (en) 1999-06-28 2000-06-27 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof

Publications (2)

Publication Number Publication Date
NO20016366D0 NO20016366D0 (no) 2001-12-27
NO20016366L true NO20016366L (no) 2002-02-27

Family

ID=16108822

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016366A NO20016366L (no) 1999-06-28 2001-12-27 Mellomprodukter for syntese av benzimidazolforbindelser, og fremgangsmåte for fremstilling derav

Country Status (18)

Country Link
US (2) US6525220B2 (de)
EP (2) EP1607385A1 (de)
KR (1) KR100731946B1 (de)
CN (2) CN1611489A (de)
AT (1) ATE336482T1 (de)
AU (1) AU5570000A (de)
CA (1) CA2377233C (de)
CZ (1) CZ20014412A3 (de)
DE (1) DE60030118T2 (de)
ES (1) ES2270843T3 (de)
HU (1) HUP0201559A3 (de)
IL (2) IL146916A0 (de)
MX (1) MXPA02000069A (de)
NO (1) NO20016366L (de)
PL (1) PL352383A1 (de)
RU (1) RU2224742C2 (de)
TW (1) TWI262180B (de)
WO (1) WO2001000570A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CN101068770B (zh) * 2004-09-28 2012-01-04 三共株式会社 制备6-取代的-1-甲基-1-h-苯并咪唑衍生物的方法及其合成中间体
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
EP2505587A1 (de) 2009-11-26 2012-10-03 Daiichi Sankyo Company, Limited Verfahren zur herstellung eines 6-substituierten 1-methyl-1h-benzimidazol-derivats und herstellung eines zwischenprodukts davon in diesem verfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2030392C1 (ru) * 1991-04-01 1995-03-10 Акционерное общество открытого типа "Пигмент" Способ получения 3-нитро-4-аминоанизола
JPH0745600A (ja) * 1993-01-20 1995-02-14 Hitachi Ltd 液中異物付着防止溶液とそれを用いたエッチング方法及び装置
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
CZ293016B6 (cs) 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
KR100666887B1 (ko) * 1997-10-08 2007-01-10 상꾜 가부시키가이샤 치환 축합 복소환 화합물

Also Published As

Publication number Publication date
US20030008907A1 (en) 2003-01-09
ATE336482T1 (de) 2006-09-15
HUP0201559A3 (en) 2004-03-01
HK1044932A1 (en) 2002-11-08
CN1249024C (zh) 2006-04-05
CA2377233A1 (en) 2001-01-04
HUP0201559A2 (en) 2002-08-28
EP1191019A4 (de) 2004-06-02
MXPA02000069A (es) 2002-07-02
CA2377233C (en) 2009-03-10
PL352383A1 (en) 2003-08-25
DE60030118T2 (de) 2007-03-15
RU2224742C2 (ru) 2004-02-27
IL146916A (en) 2008-07-08
IL146916A0 (en) 2002-08-14
US20030199580A1 (en) 2003-10-23
EP1607385A1 (de) 2005-12-21
CN1371360A (zh) 2002-09-25
WO2001000570A1 (en) 2001-01-04
US6525220B2 (en) 2003-02-25
EP1191019B1 (de) 2006-08-16
TWI262180B (en) 2006-09-21
ES2270843T3 (es) 2007-04-16
EP1191019A1 (de) 2002-03-27
NO20016366D0 (no) 2001-12-27
CN1611489A (zh) 2005-05-04
KR20020087835A (ko) 2002-11-23
US6753347B2 (en) 2004-06-22
CZ20014412A3 (cs) 2002-04-17
AU5570000A (en) 2001-01-31
KR100731946B1 (ko) 2007-06-25
DE60030118D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
RU98102128A (ru) Производные бензо[g]хинолина
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
ATE268751T1 (de) Biphenylamidin-derivate
DE60008917D1 (de) Neue 1,8-naphtyridin-2(1h)-on-derivate
EA200100090A3 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DK1059283T3 (da) Fremgangsmåde til fremstilling af neuraminidase-inhibitor ro-64-0796
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
NO20016366D0 (no) Mellomprodukter for syntese av benzimidazolforbindelser, og fremgangsmåte for fremstilling derav
ATE234086T1 (de) Creatine derivate für asthma
EA200101109A1 (ru) Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана
EP0860169A3 (de) Pyridazinon-Verbindungen enthaltenden Zusammensetzungen zur oralen Verabreichung
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
WO2006013049A3 (en) Benzyloxy derivatives as maob inhibitors
DE69914563D1 (de) Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
PL145043B1 (en) Method of obtaining concentrated derivatives of as-triazine
KR960031439A (ko) 치환 인돌 유도체
FI882956L (fi) 4-piperidyl-substituerade karboxylsyraderivat och foerfarande foer deras framstaellning.
KR970001357A (ko) 접합고리 피리딘을 함유한 벤즈이미다졸 유도체

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application